透過您的圖書館登入
IP:18.219.63.90

摘要


隨著疫苗科技的進步與流行病學的改變,今日的疫苗已非嬰幼兒的專利,青少年也有必要施打疫苗。首先,有些專為青少年設計的疫苗,例如人類乳突瘤病毒疫苗被研發出來。青少年是施打人類乳突瘤病毒疫苗的為最佳時機,可以在其開始有性行為之前建立保護力。人類乳突瘤病毒疫苗可以有效預防人類乳突瘤病毒感染及其相關的泌尿生殖器癌症,尤其是子宮頸癌。其次,部分在嬰幼兒時期打過的疫苗,疫苗所賦予的保護力到了青少年階段可能逐漸消退,有必要再追加。百日咳疫苗與B型肝炎疫苗是其中的例子,麻疹與日本腦炎也有可能需要注意。第三,有些疫苗在過去未被列入公費疫苗,大部分青少年沒有打過,因此有遭感染的風險。A肝屬於此類。台灣2003年以後出生的世代雖大部分已打過一劑水痘疫苗,只打一劑並不能完全預防水痘,可考慮打第二劑。2003年以前出生的青少年,更可以考慮施打水痘疫苗。最後,青少年扮演流感在家庭與學校間的傳播樞紐,也是優先建議每年施打流感疫苗的對象。本文將就上述各種疫苗的施打必要性、施打方法與時機、疫苗的效果與安全性等逐一介紹。

關鍵字

青少年 疫苗

並列摘要


With the advance of vaccine technologies and evolution of epidemiology, vaccination is no longer exclusively used for infants or children. Adolescents need their own vaccinations as well. First of all, some newly-developed, adolescents-targeted vaccines such as human papillomavirus vaccines are available nowadays. Adolescence is a perfect timing for HPV vaccines as they will soon grow into their sexually active ages. HPV vaccines have been proved to prevent HPV infections and certain urogenital cancers including cervical cancer. Second, some adolescents are about to lose immunity conferred by vaccinations they have received in their childhood. Pertussis, HBV, JE vaccines are among vaccines in this category. Third, some vaccines like HAV and varicella vaccines were not commonly used in earlier years and adolescents were seldom vaccinated. They can be vaccinated with these vaccines before growing into their adulthood. Finally, adolescents play a pivotal role in influenza transmission. Annual influenza vaccinations for adolescents are important for them and their families. This article is to review the epidemiology and vaccination strategies for the above mentioned diseases and vaccines in adolescents.

並列關鍵字

adolescent vaccination

參考文獻


Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
Bhatla N, Lal N, Bao YP, et al. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 2008;26:2811-7.
Harper DM, DeMars LR: Corrigendum to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017) 196-204]. Gynecol Oncol 2017;147:489.
Romanowski B, Schwarz TF, Ferguson LM, et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Hum Vaccine 2011;7:1374-86.
Chang IF, Lee PI, Lu CY, et al. Resurgence of pertussis in Taiwan during 2009-2015 and its impact on infants. J Microbiol Immunol Infect 2019;52:542-8.

延伸閱讀


國際替代計量